MEDP
Medpace Holdings Inc
Medpace Holdings Inc historical holders
total: 8
Polen Capital Management Medpace Holdings Inc transactions over time
- Total transactions:
- 19
- New positions:
- 2
- Sold out:
- 2
- Added:
- 10
- Reduced:
- 5
- Held since:
- 2023 Q4
- Held for:
- 9 quarters
- Latest activity:
- 2026 Q1
Polen Capital Management has been an institutional investor in Medpace Holdings Inc (MEDP) since 2020 Q2. According to 2026 Q2 report, Polen Capital Management doesn't hold any shares. The fund/company first acquired MEDP in 2020 Q2, initially purchasing 28,374 shares. Polen Capital Management later completely sold out the position and reinvested in MEDP again in 2023 Q4. Since the initial investment, Polen Capital Management has made 18 more transactions in this position.
When did Polen Capital Management exit their MEDP position?
Polen Capital Management no longer holds Medpace Holdings Inc (MEDP). They sold off their entire position in 2026 Q1, closing out an investment that began in 2020 Q2.
When did Polen Capital Management first invest in MEDP?
Polen Capital Management first invested in Medpace Holdings Inc (MEDP) in 2020 Q2 at the reported quarter-end price of $93.01 per share, acquiring 28,374 shares in their initial purchase.
What is Polen Capital Management's average cost basis for MEDP?
Based on historical transaction data, Polen Capital Management's estimated cost basis for Medpace Holdings Inc (MEDP) is approximately $309.00 per share. This represents their average reported price* across all buy transactions.
Has Polen Capital Management reinvested in MEDP after selling?
Yes, Polen Capital Management has shown renewed interest in Medpace Holdings Inc (MEDP). After completely selling their position, they reinitiated an investment in 2023 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $309.00
- Weighted AVG sell price:
- $351.41
MEDP transactions history by Polen Capital Management
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.00%
|
0
|
$561.65
|
|
-100% (-696)
|
-0%
|
|
2025 Q4
|
0.00%
|
696
|
$561.65
|
$390,908
|
-12.12% (-96)
|
-0%
|
|
2025 Q3
|
0.00%
|
792
|
$514.16
|
$407,215
|
-82.81% (-3,816)
|
-0.01%
|
|
2025 Q2
|
0.00%
|
4,608
|
$313.86
|
$1,446,267
|
-81.17% (-19,858)
|
-0.02%
|
|
2025 Q1
|
0.02%
|
24,466
|
$304.69
|
$7,454,599
|
+50.81% (+8,243)
|
+0.01%
|
|
2024 Q4
|
0.01%
|
16,223
|
$332.23
|
$5,389,833
|
+8.41% (+1,259)
|
+0%
|
|
2024 Q3
|
0.01%
|
14,964
|
$333.81
|
$4,995,079
|
-13.71% (-2,377)
|
-0%
|
|
2024 Q2
|
0.02%
|
17,341
|
$411.85
|
$7,141,922
|
+2.25% (+382)
|
+0%
|
|
2024 Q1
|
0.02%
|
16,959
|
$404.15
|
$6,854,019
|
+0.53% (+89)
|
+0%
|
|
2023 Q4
|
0.01%
|
16,870
|
$306.53
|
$5,171,232
|
new
|
+0.01%
|
|
2022 Q2
|
0.00%
|
$163.56
|
-100% (-4,555)
|
|||
|
2022 Q1
|
0.00%
|
$163.56
|
-96.15% (-113,670)
|
|||
|
2021 Q4
|
0.04%
|
$217.64
|
+25.08% (+23,703)
|
|||
|
2021 Q3
|
0.03%
|
$189.28
|
+8.14% (+7,111)
|
|||
|
2021 Q2
|
0.03%
|
$176.63
|
+6.67% (+5,463)
|
|||
|
2021 Q1
|
0.03%
|
$164.06
|
+21.12% (+14,292)
|
|||
|
2020 Q4
|
0.02%
|
$139.20
|
+101.36% (+34,057)
|
|||
|
2020 Q3
|
0.01%
|
$111.76
|
+18.41% (+5,225)
|
|||
|
2020 Q2
|
0.01%
|
$93.01
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.